Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Essentra full-year profit falls 26 percent on integration woes at biggest unit

Published 17/02/2017, 08:35
Updated 17/02/2017, 08:40
© Reuters.  Essentra full-year profit falls 26 percent on integration woes at biggest unit

(Reuters) - Essentra Plc (L:ESNT), a supplier of speciality plastic and packaging components, said full-year profit fell 26 percent on flagging sales at its health and personal care packaging unit, due to integration issues from an acquisition completed in 2015.

This reiterates the challenges the company has been facing, prompting it to issue profit warnings three times in the past 12 months.

Essentra shares opened 3.9 percent lower at 405 pence at 0805 GMT on Friday on the London Stock Exchange.

The health and personal care packaging unit, which bought the specialist packaging division of the Clondalkin Group, is the company's biggest business, accounting for about 40 percent of total revenue. Operating profit at the unit fell 44 percent.

Milton Keynes, Buckinghamshire-based Essentra had indicated on Jan. 23 that sales at the business were more challenging than previously expected after the consolidation of assets bought from the Clondalkin Group.

The company had said in January that its new chief executive had initiated a strategic review of the company and that the health and personal care unit would be receiving "specific short-term focus and remedial attention" from him. [nL4N1FD2T9]

Essentra does not expect an improvement in the unit's performance in the near term, the company said on Friday, adding that the challenges faced at the business would hurt its like-for-like sales and adjusted operating profit in 2017.

Essentra completed its $455 million acquisition of the Clondalkin Group assets from an affiliate of Warburg Pincus in February 2015. (http://reut.rs/2kZhIp2)

"In particular, the integration issues primarily relating to the Clondalkin acquisition in Health & Personal Care Packaging... not only resulted in additional cost but also in an accelerating decline in the underlying trading position at the impacted sites," the company said in a statement.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company, which was formed after being demerged from Bunzl Plc (L:BNZL) in June 2005, said full-year pretax profit fell to 119 million pounds ($148.62 million) from 161 million pounds a year earlier. [nRSQ1628Xa]

Like-for-like revenue, excluding its Porous Technologies business that is set to be divested, fell 9.1 percent to 999 million pounds at constant currency rates.

($1 = 0.8007 pounds)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.